PMID- 22875402 OWN - NLM STAT- MEDLINE DCOM- 20121228 LR - 20181201 IS - 2040-3372 (Electronic) IS - 2040-3364 (Linking) VI - 4 IP - 18 DP - 2012 Sep 21 TI - Therapeutic application of injectable thermosensitive hydrogel in preventing local breast cancer recurrence and improving incision wound healing in a mouse model. PG - 5686-93 LID - 10.1039/c2nr30731f [doi] AB - Many drug delivery systems (DDSs) have been investigated for local targeting of malignant disease with the intention of increasing anti-tumor activity and minimizing systemic toxicity. An injectable thermosensitive hydrogel was applied to prevent locoregional recurrence of 4T1 breast cancer in a mouse model. The presented hydrogel, which is based on poly(ethyleneglycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE), flows freely at normal temperature, forms a gel within seconds in situ at body temperature, and eventually releases the drug in a consistent and sustained fashion as it gradually biodegrades. Locoregional recurrence after primary tumor removal was significantly inhibited in mice treated with the paclitaxel (PTX)-loaded PECE hydrogel subcutaneously (9.1%) administered, compared with the blank hydrogel (80.0%), systemic (77.8%) and locally (75.0%) administered PTX, and the control group (100%) (P < 0.01). In addition, tensile strength measurements of the surgical incisions showed that the PECE hydrogel accelerates wound healing at postoperative day 7 (P < 0.05), and days 4 and 14 (P > 0.05), in agreement with histopathological examinations. This novel DDSs represents a promising approach for local adjuvant therapy in malignant disease. FAU - Lei, Na AU - Lei N AD - State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China. FAU - Gong, ChangYang AU - Gong C FAU - Qian, ZhiYong AU - Qian Z FAU - Luo, Feng AU - Luo F FAU - Wang, Cheng AU - Wang C FAU - Wang, HeLan AU - Wang H FAU - Wei, YuQuan AU - Wei Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120809 PL - England TA - Nanoscale JT - Nanoscale JID - 101525249 RN - 0 (Drug Carriers) RN - 0 (Polyesters) RN - 0 (poly(ethylene glycol)-poly(caprolactone)-poly(ethylene glycol)) RN - 25852-47-5 (Hydrogel, Polyethylene Glycol Dimethacrylate) RN - 3WJQ0SDW1A (Polyethylene Glycols) RN - P88XT4IS4D (Paclitaxel) SB - IM MH - Animals MH - Breast Neoplasms/drug therapy/mortality/pathology MH - Cell Line, Tumor MH - Disease Models, Animal MH - Drug Carriers/*chemistry MH - Female MH - Hydrogel, Polyethylene Glycol Dimethacrylate/*chemistry MH - Mice MH - Mice, Inbred BALB C MH - Paclitaxel/administration & dosage MH - Polyesters/chemistry MH - Polyethylene Glycols/chemistry MH - Secondary Prevention MH - Temperature MH - Transplantation, Homologous MH - Wound Healing EDAT- 2012/08/10 06:00 MHDA- 2012/12/29 06:00 CRDT- 2012/08/10 06:00 PHST- 2012/08/10 06:00 [entrez] PHST- 2012/08/10 06:00 [pubmed] PHST- 2012/12/29 06:00 [medline] AID - 10.1039/c2nr30731f [doi] PST - ppublish SO - Nanoscale. 2012 Sep 21;4(18):5686-93. doi: 10.1039/c2nr30731f. Epub 2012 Aug 9.